Search clinical trials for: Antirheumatic Agents

Total 187049 results

Armando Santoro, MD

Unknown

Evaluation of Immunological Reconstitution After Haploidentical Bone Marrow Transplantation

Lymphoma

Italy
Han weidong

Unknown

Treatment of CD20 Antibody Plus CIK for Patients With Refractory Lymphomas (CIK)

Lymphomas
Henri Mondor University Hospital
Roche Pharma AG

Unknown

The ITP-RITUX Cohort: Rituximab in Immune ThrombocytoPenia. (ITP-RITUX)

Purpura, Thrombocytopenic, Idiopathic | Autoimmune Thrombocytopenia

France
PerCuro Clinical Research Ltd

Unknown

Observational Study of Rituxan in Rheumatoid Arthritis Patients in Routine Clinical Practice

Rheumatoid Arthritis

Canada
Groupe Français de Pneumo-Cancérologie
Baxter Healthcare Corporation; Amgen

Unknown

Second-line Treatment in Patients With Small Cell Lung Cancer (SCLC)

Small Cell Lung Cancer

France
Medicpen AB

Completed

An Investigational Study to Test Usability of the Electronic Dosing Equipment Medicpen

Crohn's Disease | Ulcerative Colitis

Sweden
Sheba Medical Center

Unknown

Magnetic Resonance (MR) Spectroscopy In Familial Mediterranean Fever (FMF) Patients

Familial Mediterranean Fever

Israel
AbbVie

Recruiting

Study to Assess Speed of Onset and Durability of Effectiveness of Upadacitinib in Adult Participants With Moderate to Severe Crohn's Disease (CD) in Real World Clinical Practice. (UPlift)

Crohn's Disease

Australia, France, Germany, Hungary
AbbVie

Recruiting

Study of Oral Upadacitinib to Assess Change in Disease Activity in Adult Participants With Ulcerative Colitis (EUROPE)

Ulcerative Colitis

Germany, Austria
AbbVie

Recruiting

A Study to Assess Change in Disease Activity in Adolescents and Adults With Moderate to Severe Prurigo-type Atopic Dermatitis in Japan Who Are Treated With Oral Upadacitinib (ADMIRE)

Atopic Dermatitis

Japan
AbbVie

Recruiting

A Study to Evaluate Adverse Events and Change in Disease State of Oral Upadacitinib in Adolescent Participants Ages 12 to <18 Years Old Diagnosed With Atopic Dermatitis (AD)

Atopic Dermatitis

Japan
AbbVie

Active, not recruiting

Real World Study of Oral Upadacitinib Tablets to Assess Adverse Events and Change in Disease Activity in Adolescent and Adult Chinese Participants With Atopic Dermatitis

Atopic Dermatitis (AD)

China
AbbVie

Active, not recruiting

A Study of Oral Upadacitinib Tablets to Assess the Change in Disease Symptoms in Adult Canadian Participants With Moderate to Severe Rheumatoid Arthritis (CLOSEUP)

Rheumatoid Arthritis (RA)

Canada
Groupe Hospitalier Paris Saint Joseph

Completed

Assessment of Netosis During COVID-19, Under Treatment With Anakinra, an Interleukin-1 Receptor Antagonist (NET_COV)

Covid19

France
AbbVie

Active, not recruiting

An Observational Study to Assess the Impact of Upadacitinib in Adult Hungarian Participants With Moderate to Severe Rheumatoid Arthritis (RA) in Real-World Practice (UPDATE)

Rheumatoid Arthritis

Hungary
University of Colorado, Denver

Completed

Comparison of Brain Atrophy Rates, Cognition, and Patient-Reported Outcomes in MS Patients Using Long-term Fingolimod and Glatiramer Acetate

Multiple Sclerosis

United States
Janssen-Cilag S.p.A.

Completed

A Study in Participants With a Newly Confirmed Diagnosis of Spondyloarthritis (SpA) Who Are New to Conventional, Targeted and Biological DMARDs (SIRENA)

Spondyloarthritis, Axial and Peripheral

Italy
UCB BIOSCIENCES, Inc.
Syneos Health; Parexel

Terminated

UCB Cimzia Pregnancy Follow-up Study

Rheumatoid Arthritis (RA) | Crohn's Disease (CD) | Psoriatic Arthritis (PsA) | Axial Spondyloarthritis and Ankylosing Spondylitis

United States
Pfizer

Completed

Patient-Reported Outcomes In Rheumatoid Arthritis Patients Treated With Tofacitinib Or Biological Disease-Modifying Antirheumatic Drugs (DMARDs) In Real Life Conditions

Arthritis, Rheumatoid

Colombia, Peru
Assiut University

Unknown

Adherence Rate to DMARDS in Egyptian Patients With RA

Rheumatoid Arthritis
Hoffmann-La Roche

Completed

ARMONIA: An Observational Study of Biologic Drugs in Monotherapy or Combination With DMARDs in Italian Clinical Practice and the Efficacy and Safety of RoActemra/Actemra (Tocilizumab) Monotherapy in Patients With Rheumatoid Arthritis

Rheumatoid Arthritis

Italy
UCB Pharma

Completed

Long Term Effects of an Early Response to Certolizumab Pegol (CZP, Cimzia®) in Rheumatoid Arthritis (RA) Patients (RA-PROACTIVE)

Arthritis,Rheumatoid

Ireland, United Kingdom
UCB Pharma

Terminated

Certolizumab Pegol for the Treatment of Patients With Active Rheumatoid Arthritis (RA) and Crohn's Disease (CD)

Rheumatoid Arthritis | Crohn's Disease

Russian Federation
Sanofi

Terminated

Elitek (Rasburicase) Immuno-Monitoring Study

Tumor Lysis Syndrome

United States
National Chung Hsing University
Taichung Veterans General Hospital

Completed

Pharmacogenetics of Antifolate Disease Modifying Anti-Rheumatic Drugs in Rheumatoid Arthritis in Taiwan

Rheumatoid Arthritis
AbbVie

Recruiting

An Observational Study to Assess Change in Disease Activity and Adverse Events in Adolescent and Adult Participants With Moderate to Severe Active Crohn's Disease (CD) in Japan

Crohn's Disease

Japan
AbbVie

Recruiting

An Observational Study to Assess Change in Disease Activity and Adverse Events of Rinvoq in Adult Participants With Moderate to Severe Ulcerative Colitis (UC) in Japan

Ulcerative Colitis

Japan
AbbVie

Recruiting

An Observational Study to Assess Change in Disease Activity and Use of Upadacitinib Tablets in Adolescent and Adult Participants With Moderate to Severe Atopic Dermatitis in Real World (UPDATE)

Atopic Dermatitis

France
AbbVie

Recruiting

Study To Assess Frequency Of Serious Infections In Clinical Practice In Japan For Adult Participants With Rheumatoid Arthritis Receiving Oral RINVOQ Tablets

Rheumatoid Arthritis (RA)

Japan
UMC Utrecht
Eli Lilly and Company; Sanofi; AbbVie; LEO Pharma; Academisch Ziekenhuis Groningen

Recruiting

BioDay Registry: Data Collection Regarding the Use of New Systemic Treatment Options in Patients With Atopic Dermatitis (BioDay)

Atopic Dermatitis

Netherlands
Diakonhjemmet Hospital
Vestre Viken Hospital Trust; University Hospital of North Norway; St. Olavs Hospital and other collaborators

Recruiting

The Norwegian Antirheumatic Drug Register (NOR-DMARD)

Inflammatory Joint Diseases

Norway
AbbVie

Completed

A Study to Assess the Change in Disease State in Adult Participants Being Treated With Oral Upadacitinib Tablets in Participants With Oligo- or Poly-artIcular Psoriatic Arthritis (UPJOINT)

Psoriatic Arthritis

Canada, Germany
AbbVie

Active, not recruiting

A Study of Oral Upadacitinib Tablets to Assess Treatment Patterns, Achievement of Treatment Targets and Maintenance of Response in Adult Participants With Moderate to Severe Rheumatoid Arthritis (UPHOLD)

Rheumatoid Arthritis (RA)

Argentina, Australia, Austria, Belgium, France, Germany, Greece, Ireland, Israel, Italy, Kuwait, Mexico, Russian Federation, Saudi Arabia, Spain, Switzerland, Taiwan, United Arab Emirates, Uruguay
California Pacific Medical Center Research Institute

Completed

CPMC Early Undifferentiated Arthritis Registry (CEUAR)

Early Undifferentiated Arthritis

United States
UCB Pharma
National Data Bank for Rheumatic Diseases (NDB)

Completed

National Data Bank for Rheumatic Disease Registry Study of Safety in Patients With Rheumatoid Arthritis Treated With Cimzia® or Disease-modifying Antirheumatic Drugs (DMARDs)

Rheumatoid Arthritis
University of British Columbia
Teva Pharmaceuticals USA

Completed

Correlation Between PET and Advanced MRI in Multiple Sclerosis

Multiple Sclerosis

Canada
UCB Biopharma S.P.R.L.
Parexel

Completed

A Study to Assess the Effectiveness of Certolizumab Pegol in Patients With Axial Spondyloarthritis in Daily Life (CIMAX)

Axial Spondyloarthritis

Belgium, Germany, Greece, Italy, Spain, United Kingdom
Hoffmann-La Roche

Completed

An Observational Study in Clinical Practice Management of Patients With Biological Drugs in Monotherapy

Rheumatoid Arthritis

Spain
University at Buffalo
Teva Pharmaceuticals USA

Completed

Studying the Effects of Copaxone on Retinal Health Using Optical Tomography Over 24 Months (GAO)

Multiple Sclerosis

United States
UCB Pharma SA
ReSearch Pharmaceutical Services, Inc.

Completed

Health-related Quality of Life and Patient-reported Outcomes in Rheumatoid Arthritis Patients Treated With Certolizumab Pegol (SONAR-12)

Rheumatoid Arthritis

Spain
University of Southern California
Teva Pharmaceuticals USA

Completed

Glatiramer Acetate for Multiple Sclerosis With Autoimmune Comorbidities

Relapsing Remitting Multiple Sclerosis

United States
Selcuk University

Completed

Interleukin-1 Receptor Antagonist Gene Polymorphism and Adverse Pregnancy Outcome in Turkish Women (IRAGPAAOITW)

Periodontitis
Seoul National University Hospital

Unknown

A Pilot Study for Pharmacokinetic/Pharmacodynamic (PK/PD) Parameter of Allopurinol and Its Metabolite-oxypurinol After Once-daily Allopurinol in Chronic Kidney Disease Patient (Allopurinol)

Chronic Kidney Disease

Korea, Republic of
Teva Neuroscience, Inc.

Completed

A Study to Evaluate Readiness to Self-inject on Adherence and Compliance to Copaxone® Therapy

Multiple Sclerosis
Bristol-Myers Squibb

Completed

Effect of Patient Cost Sharing on Treatment Discontinuation Among Rheumatoid Arthritis Patients

Rheumatoid Arthritis
Vifor Fresenius Medical Care Renal Pharma

Recruiting

Avacostar - (PASS) (Avacostar)

ANCA-associated Vasculitis

United Kingdom, Germany
Xinhua Hospital, Shanghai Jiao Tong University...

Recruiting

A Study of Rituximab in Frontline Therapy for Glomerulonephritis

Glomerulonephritis

China
Peking University Third Hospital
Peking University First Hospital; Shanxi Province Cancer Hospital; 307 Hospital... and other collaborators

Recruiting

Ibrutinib Combined With Bendamustine and Rituximab in Newly Diagnosed Mantle Cell Lymphoma Patients Who Aged > 65 Years

Mantle Cell Lymphoma (MCL)

China
Fundación Pública Andaluza para la gestión de la...

Recruiting

Persistence of Biological Treatment and Inhibitors of Jak Kinases in Patients With Rheumatoid Arthritis. (Arthritis)

Arthritis, Rheumatoid

Spain
University Hospital Birmingham NHS Foundation Trust
Merck Sharp & Dohme LLC

Recruiting

Subclinical Cytomegalovirus Reactivation in Acute ANCA-associated Vasculitis (REACTIVAS)

ANCA Associated Vasculitis

United Kingdom

3

Subscribe